Art. 88 Directive (EU) 2001/83

In forcesince 30 Apr 2004cited 46×
1.

Member States shall prohibit the advertising to the general public of medicinal products which:

(a)

are available on medical prescription only, in accordance with Title VI;

(b)

contain substances defined as psychotropic or narcotic by international convention, such as the United Nations Conventions of 1961 and 1971.

2.

Medicinal products may be advertised to the general public which, by virtue of their composition and purpose, are intended and designed for use without the intervention of a medical practitioner for diagnostic purposes or for the prescription or monitoring of treatment, with the advice of the pharmacist, if necessary.

3.

Member States shall be entitled to ban, on their territory, advertising to the general public of medicinal products the cost of which may be reimbursed.

4.

The prohibition contained in paragraph 1 shall not apply to vaccination campaigns carried out by the industry and approved by the competent authorities of the Member States.

5.

The prohibition referred to in paragraph 1 shall apply without prejudice to Article 14 of Directive 89/552/EEC.

6.

Member States shall prohibit the direct distribution of medicinal products to the public by the industry for promotional purposes.

The 10 that are cited most themselves, of 46.

  • Directive (EU) 2004/27Lawamends

  • Judgment of the Court (Second Chamber) of 8 November 2007. Gintec International Import-Export GmbH v Verband Sozialer Wettbewerb eV.Decisioninterprets

    Reference should be made, by way of example, first, to Article 88(3) of Directive 2001/83, which permits Member States to ban, on their territory, advertising of medicinal products the cost of which may be reimbursed.

    8 Nov 2007 · 62005CJ0374

  • Judgment of the Court of 11 December 2003. Deutscher Apothekerverband eV v 0800 DocMorris NV and Jacques Waterval.Decisioninterprets

    Second, the distinction between medicinal products which are subject to prescription and those which are not, which is based on those criteria and which thus concerns the potential danger of the product concerned, is applied in the …

    11 Dec 2003 · 62001CJ0322

  • Judgment of the Court (Third Chamber) of 5 May 2011. MSD Sharp & Dohme GmbH v Merckle GmbH.Decisioninterprets

    This reference for a preliminary ruling concerns the interpretation of Article 88(1)(a) of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human …

    5 May 2011 · 62009CJ0316

  • Judgment of the Court (Third Chamber) of 1 October 2020. A v Daniel B and Others.Decision

    Title VIII, entitled ‘Advertising’, and Title VIIIa, entitled ‘Information and advertising’ of Directive 2001/83 contain, respectively, Articles 86 to 88 and Articles 88a to 100 of that directive.

    1 Oct 2020 · 62018CJ0649

  • Judgment of the Court (Fourth Chamber) of 15 July 2021. DocMorris NV v Apothekerkammer Nordrhein.Decision

    The referring court notes that only advertising of a particular product falls within the scope of the HWG, as opposed to general advertising for an undertaking. However, advertising for the entire range of products of a pharmacy, such as …

    15 Jul 2021 · 62020CJ0190

  • Judgment of the Court (Grand Chamber) of 22 December 2022. SIA 'EUROAPTIEKA' v Ministru kabinets.Decision

    However, as regards, on the one hand, the provisions of Title VIII of Directive 2001/83, namely those in Articles 86 to 88 of that directive, it should be noted that those provisions lay down general and fundamental rules relating to …

    22 Dec 2022 · 62020CJ0530

  • Judgment of the Court (Fourth Chamber) of 22 April 2010. The Queen, on the application of Association of the British Pharmaceutical IndustryDecision

    However, such reasoning cannot be transposed to cases where information about a medicinal product is disseminated by the public authorities themselves, for example where an epidemic or pandemic occurs. It is apparent, in particular, from …

    22 Apr 2010 · 62009CJ0062

  • Judgment of the Court (Third Chamber) of 5 May 2011. Novo Nordisk AS v Ravimiamet.Decision

    It is observed that the provisions of Title VIII of Directive 2001/83 are general in nature.

    5 May 2011 · 62009CJ0249

  • Judgment of the Court (Third Chamber) of 11 June 2020. ratiopharm GmbH v Novartis Consumer Health GmbH.Decision

    Under Article 88 of that directive: ‘1. Member States shall prohibit the advertising to the general public of medicinal products which: are available on medical prescription only, in accordance with Title VI; contain substances defined …

    11 Jun 2020 · 62018CJ0786